Samantha Semenkow
Stock Analyst at Citigroup
(0.78)
# 3,868
Out of 4,911 analysts
44
Total ratings
27.78%
Success rate
-21.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WVE Wave Life Sciences | Initiates: Buy | $16 | $8.40 | +90.48% | 1 | Jul 16, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | $10 → $1.5 | $4.21 | -64.37% | 3 | May 27, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $17 → $13 | $1.66 | +683.13% | 3 | May 16, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.50 | +166.67% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $591.99 | +35.64% | 6 | May 9, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $60 | $17.94 | +234.45% | 1 | May 2, 2025 | |
| BIOA BioAge Labs | Maintains: Neutral | $7 → $5 | $4.62 | +8.23% | 3 | Mar 24, 2025 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $12 | $3.24 | +270.37% | 1 | Dec 2, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $27 → $31 | $20.97 | +47.83% | 2 | Aug 9, 2024 | |
| SANA Sana Biotechnology | Maintains: Buy | $8 → $15 | $4.95 | +203.03% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $6.98 | +1,046.13% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.88 | +260.82% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $3.15 | +376.19% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $55.07 | +30.74% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $16.95 | +194.99% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $21.72 | +157.83% | 3 | Aug 9, 2023 |
Wave Life Sciences
Jul 16, 2025
Initiates: Buy
Price Target: $16
Current: $8.40
Upside: +90.48%
Prime Medicine
May 27, 2025
Downgrades: Neutral
Price Target: $10 → $1.5
Current: $4.21
Upside: -64.37%
Cabaletta Bio
May 16, 2025
Maintains: Buy
Price Target: $17 → $13
Current: $1.66
Upside: +683.13%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.50
Upside: +166.67%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $591.99
Upside: +35.64%
Structure Therapeutics
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $17.94
Upside: +234.45%
BioAge Labs
Mar 24, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.62
Upside: +8.23%
Voyager Therapeutics
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $3.24
Upside: +270.37%
Catalyst Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $20.97
Upside: +47.83%
Sana Biotechnology
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $4.95
Upside: +203.03%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $6.98
Upside: +1,046.13%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.88
Upside: +260.82%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $3.15
Upside: +376.19%
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $55.07
Upside: +30.74%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $16.95
Upside: +194.99%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $21.72
Upside: +157.83%